Strategy for hepatocellular carcinoma from the view point of viral status

从病毒状态角度治疗肝细胞癌的策略

基本信息

  • 批准号:
    09671330
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1997
  • 资助国家:
    日本
  • 起止时间:
    1997 至 1998
  • 项目状态:
    已结题

项目摘要

Serum markers for Hepatitis B and/or C virus were detected in about 97% of patients who underwent liver resection for hepatocellular carcinoma (HCC) in our department. In 1 % of the patients, hepatitic B virus gene was detected in HCC tissue. Hepatitis G virus RNA was detected in sera in 12 of 213 patients. The 12 patients also had serum markers for hepatitis B virus (HBV) or hepatitis C virus (HCV), indicating that the hepatitis G virus has poor association with HCC.The age was younger in patients infected with HBV than in patients infected with HCV.The tumor size was larger in patients infected with HBV than in patients infected with HCV.The amount of HBV sometimes increased after operation, followed by increase in alanine aminotransferase activity, in patients with wild-type HBV and large amount of HBV.In patients infected with HBV, the risk factors for recurrence included low platelet count, wild-type HBV, high viral load, positive surgical margin, and nonantomic resection. In patients infected with HCV, the risk factors included high age, positive serum HCV RNA, high activities of alanine and aspartate aminotransferase, larged tumor size (more than 4cm), multiple tumors, and portal invasion. Interferon therapy after resection of HCC may be useful to prevent recurrence. Extended resection (anatomic resection) is indicated for patients infected with HBV.For patients infected with HCV, not only complete resection of HCC but a1so strategy for HCV are necessary.
在我们科室接受肝细胞癌 (HCC) 肝切除术的患者中,约 97% 检测到乙型肝炎和/或丙型肝炎病毒血清标志物。 1%的患者在HCC组织中检测到乙型肝炎病毒基因。 213 名患者中有 12 名患者的血清中检测到了 G 型肝炎病毒 RNA。 12例患者还存在乙型肝炎病毒(HBV)或丙型肝炎病毒(HCV)血清标志物,表明庚型肝炎病毒与HCC的相关性较差。HBV感染者的年龄比HCV感染者年轻。HBV感染者的肿瘤体积比HCV感染者大。术后HBV含量有时升高,随后丙氨酸升高。 转氨酶活性,野生型HBV和大量HBV感染者。在HBV感染者中,复发的危险因素包括血小板计数低、野生型HBV、高病毒载量、手术切缘阳性和非解剖切除。 HCV感染患者的危险因素包括高龄、血清HCV RNA阳性、丙氨酸和天冬氨酸转氨酶活性高、肿瘤体积大(大于4cm)、多发肿瘤以及门脉侵犯。 HCC 切除后的干扰素治疗可能有助于预防复发。乙型肝炎病毒感染患者需要扩大切除(解剖切除)。丙型肝炎病毒感染患者不仅需要完整切除肝癌,还需要针对丙型肝炎病毒采取相应的治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Shoji Kubo,et al.: "High prelalence of infection with hepatitis B and C viruses in patients with hepatocellular carcinoma in Japan" Hepatogastroenteral. (in press).
Shoji Kubo 等人:“日本肝细胞癌患者中乙型和丙型肝炎病毒感染的高患病率”肝胃肠病。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Kubo,etal.: "High maligncmy of leplto collulan carcinamain in alcholic patiemts with heptitis cvius" Surgery. 121(4). 425-429 (1997)
S.Kubo 等人:“酒精性肝炎患者中细小颗粒癌的高度恶性”手术。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
首藤太一 他: "同時性多発肝細胞癌に対する手術用式とその成績" 日本外科系連合学会雑誌. 23(1). 69-74 (1998)
Taichi Shuto 等:“同步性多发性肝细胞癌的手术方案及其结果”,日本外科学会杂志 23(1) 69-74 (1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
久保正二 他: "肝炎ウイルス病態からみた肝細胞癌治療戦略" 消化器外科. 21(4). 425-430 (1998)
Shoji Kubo 等人:“从肝炎病毒病理学的角度治疗肝细胞癌”,《胃肠外科》21(4)425-430(1998)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Kubo, H.Kinoshita, K.Hirohashi, H.Tanaka, T.Tsukamoto, T.Shuto, Y.Morimoto, A.Kanazawa, S.Mikami, C.Sakata: "The efficacy of preoperative portal vein embolization prior to a major hepatectomy for patients with an impaired liver function : A retrospectiv
S.Kubo、H.Kinoshita、K.Hirohashi、H.Tanaka、T.Tsukamoto、T.Shuto、Y.Morimoto、A.Kanazawa、S.Mikami、C.Sakata:“术前门静脉栓塞术的疗效
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUBO Shoji其他文献

KUBO Shoji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUBO Shoji', 18)}}的其他基金

Identification of mechanism of hepatocarcinogenesis by analysi of microRNA
通过microRNA分析鉴定肝癌发生机制
  • 批准号:
    23591994
  • 财政年份:
    2011
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of hepatocarcinogenesis in patients without infection of hepatitis B and C viruses by molecular biological analysis
分子生物学分析未感染乙型、丙型肝炎病毒患者肝癌发生机制
  • 批准号:
    20591616
  • 财政年份:
    2008
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Constitution of a system of microarray CGH analysis for wide-screening and a research for genes responsible for hepatocellular carcinoma
用于广泛筛选的微阵列CGH分析系统的构建和肝细胞癌相关基因的研究
  • 批准号:
    17591431
  • 财政年份:
    2005
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of hepatocarcinogenesis by mitochondria DNA analysis and its clinical signifianoe
线粒体DNA分析肝癌发生机制及其临床意义
  • 批准号:
    15591430
  • 财政年份:
    2003
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of nitric oxide in the regulation of hepatic microcirculation under surgical stress
一氧化氮在手术应激下肝脏微循环调节中的作用
  • 批准号:
    07671416
  • 财政年份:
    1995
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

MRI hemodynamic analysis of portal vein flow after liver resection/liver transplantation
肝切除/肝移植术后门静脉血流的MRI血流动力学分析
  • 批准号:
    21K16472
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The HeLiX Trial: A Randomized Controlled Trial of Tranexamic Acid Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection
HeLiX 试验:氨甲环酸与安慰剂相比减少肝切除患者围手术期输血的随机对照试验
  • 批准号:
    372220
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus radical liver resection alone in incidentally detected gallbladder carcinoma after simple cholecystectomy – A phase III study utilizing the German Registry
在简单胆囊切除术后偶然发现的胆囊癌中,使用吉西他滨加顺铂进行新辅助化疗,然后进行根治性肝切除术与单纯根治性肝切除术比较 – 利用德国注册中心进行的一项 III 期研究
  • 批准号:
    316590476
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Clinical Trials
Scientific research on the cell replacement therapy with Muse cells after major liver resection
大面积肝切除术后Muse细胞细胞替代疗法的科学研究
  • 批准号:
    17K10676
  • 财政年份:
    2017
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The HeLiX Trial: A Randomized Controlled Trial of Tranexamic Acid Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection
HeLiX 试验:氨甲环酸与安慰剂相比减少肝切除患者围手术期输血的随机对照试验
  • 批准号:
    351765
  • 财政年份:
    2016
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
The HeLiX Trial: A Randomized Controlled Trial of Tranexamic Acid Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection
HeLiX 试验:氨甲环酸与安慰剂相比减少肝切除患者围手术期输血的随机对照试验
  • 批准号:
    366542
  • 财政年份:
    2016
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
Development of the piezo-actuator pulsed water jet system for laparoscopic liver resection
腹腔镜肝脏切除术压电驱动器脉冲水射流系统的开发
  • 批准号:
    15K10018
  • 财政年份:
    2015
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
External Validation of a Nomogram Predicting Peri-Operative Bleeding Risks in Patients Undergoing Liver Resection
预测肝切除患者围手术期出血风险的列线图的外部验证
  • 批准号:
    331324
  • 财政年份:
    2014
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Studentship Programs
Navigation using real-time intraoperative ultrasonography in anatomic liver resection
实时术中超声在解剖性肝切除术中的导航
  • 批准号:
    25861176
  • 财政年份:
    2013
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Tranexamic Acid Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Major Liver Resection: A Pilot Randomized Controlled Trial
氨甲环酸与安慰剂相比,可减少接受主要肝切除术的患者围手术期输血:一项随机对照试验
  • 批准号:
    297779
  • 财政年份:
    2013
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了